Search Within

Harper Hubbeling

Formats
  1. Meeting Abstract (36)
  2. Journal Article (8)
  3. Research Letter (1)
Groups
  1. GME, Radiation Oncology (45)
  2. Graduate Medical Education (45)
  3. Radiation Oncology, Department of (43)
  4. Survivorship Research (39)
  5. Department of Medicine (32)
  6. Hematologic Malignancies, Division of (27)

More Groups

People
  1. Brandon Imber (41)
  2. Joachim Yahalom (35)
  3. Carla Hajj (33)
  4. Kathryn Tringale (28)
  5. Beatrice Fregonese (21)
  6. Michael Scordo (19)

More People

Years
  1. 2024 (3)
  2. 2023 (19)
  3. 2022 (18)
  4. 2021 (4)
  5. 2019 (1)
Publications
  1. Blood (13)
  2. International Journal of Radiation Oncology, Biology, Physics (8)
  3. Hematological Oncology (7)
  4. Radiotherapy and Oncology (4)
  5. Clinical Cancer Research (3)
  6. Transplantation and Cellular Therapy (3)

More Publications

Publishers
  1. Elsevier Inc. (15)
  2. American Society of Hematology (14)
  3. Wiley Blackwell (7)
  4. American Association for Cancer Research (3)
  5. American Medical Association (1)
  6. American Society of Clinical Oncology (1)

More Publishers

Results (45)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Salvage radiotherapy as a bridge for relapsed secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K. R.; Hajj, C.; Hubbeling, H. G.; Sarkar, R. R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Pike, L. R. G.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • 18F-FDG PET/CT features as potent imaging biomarkers of efficacy and toxicity in large-B-cell lymphoma treated with CAR-T cell therapy
    Meeting Abstract

    Leithner, D.; Flynn, J. R.; Mauguen, A.; Devlin, S. M.; Fei, T.; Imber, B. S.; Hubbeling, H.; Mayerhoefer, M. E.; Lafontaine, D.; Michaud, L.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2023)

    Fulltext@MSK | Save
  • Very low dose radiation therapy for indolent lymphomas: Comparing "Big Boom" (4 Gy x 1) vs. "Boom Boom" (2 Gy x 2)
    Meeting Abstract

    Hajj, C.; Lee, J.; Boe, L. A.; Fregonese, B.; Lebow, E. S.; Wijetunga, N. A.; Hubbeling, H. G.; Tringale, K. R.; Freret, M. E.; Imber, B. S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2023)

    Fulltext@MSK | Save
  • Multicenter experience with radiotherapy for relapse after chimeric antigen receptor T cell therapy in non‐Hodgkin lymphoma
    Meeting Abstract

    Hubbeling, H.; Figura, N.; Ladbury, C.; Keit, E. R.; Chew, J.; Fregonese, B.; Silverman, E. A.; Hajj, C.; Shah, G.; Kambhampati, S.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • CNS radiotherapy as bridging prior to CAR T‐cell therapy for hematologic malignancies
    Meeting Abstract

    Cederquist, G.; Hubbeling, H.; Tringale, K.; Shah, G.; Alarcon Tomas, A.; Shouval, R.; Hajj, C.; Fregonese, B.; Lee, J.; Dahi, P. B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiation in a new era of multiple myeloma management: Patterns of utilization, clinical, radiologic, and biochemical outcomes, and possible genomic correlates of response
    Meeting Abstract

    Dreyfuss, A. D.; Fregonese, B.; Ma, J.; Reith, S.; Cederquist, G.; Hubbeling, H.; Tringale, K. R.; Wijetunga, N. A.; Usmani, S.; Hajj, C.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Radiotherapy as an effective bridge for chemo‐refractory or progressive secondary CNS lymphoma
    Meeting Abstract

    Cederquist, G.; Tringale, K.; Hajj, C.; Hubbeling, H.; Sarkar, R.; Ma, J.; Dreyfuss, A.; Fregonese, B.; Lee, J.; Salles, G.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Genetic alterations in follicular lymphoma predict response to very low dose radiotherapy
    Meeting Abstract

    Wijetunga, N. A.; Lebow, E.; Chan, A.; Lee, J.; Fregonese, B.; Hajj, C.; Cedarquist, G.; Hubbeling, H.; Ma, J.; Sarkar, R.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Very low dose radiation therapy for indolent lymphoma: Comparing "Big Boom" (4GY × 1) versus "Boom Boom" (2GY × 2)
    Meeting Abstract

    Hajj, C.; Lee, J.; Boe, L.; Fregonese, B.; Lebow, E.; Wijetunga, N. A.; Hubbeling, H.; Tringale, K.; Freret, M.; Imber, B.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save
  • Dynamics of radiomic features following bridging therapy determine CD19 chimeric antigen receptor (CAR) T‐cell therapy outcome
    Meeting Abstract

    Imber, B. S.; Silverman, E. A.; Leithner, D.; Hubbeling, H.; Shah, G. L.; Fregonese, B.; Sanin, B. W.; Tomas, A. A.; Parascondola, A.; Saldia, A.; more...
    Hematological Oncology (2023)

    Fulltext@MSK | Save